# An Autocrine Regulator Loop Involving Tumor Necrosis Factor and Chemokine (C-C motif) Ligand-2 Is Activated by Transforming Growth Factor-β in Rat Basophilic Leukemia-2H3 Mast Cells

**Authors:** Dulce Avila-Rodríguez, Alfredo Ibarra-Sánchez, Marcela Sosa-Garrocho, Genaro Vázquez-Victorio, Cassandre Caligaris, Isabel Anaya-Rubio, Deisy Segura-Villalobos, Ulrich Blank, Claudia González-Espinosa, Marina Macias-Silva

PMC · DOI: 10.3390/ijms26094263 · 2025-04-30

## TL;DR

This study shows how TGF-β activates a loop involving TNF and CCL-2 in mast cells, promoting inflammation in a specific cell type.

## Contribution

The discovery of a TGF-β-induced autocrine loop involving TNF and CCL-2 in RBL-2H3 mast cells.

## Key findings

- TGF-β induces CCL-2 secretion in RBL-2H3 mast cells but not in BMMCs.
- CCL-2 secretion depends on actin rearrangements and early TNF secretion.
- TNF signaling forms an autocrine loop that cooperates with TGF-β to promote CCL-2 release.

## Abstract

TGF-β is a pleiotropic cytokine with both stimulatory and inhibitory effects on immune cells, depending on the microenvironmental context. It targets mast cells (MCs) in different physio-pathological conditions, such as inflammation and cancer. Besides acting as a potent chemoattractant for MCs, TGF-β regulates many other aspects of MCs’ physiology, including the secretion of many regulatory molecules. MCs secrete a variety of mediators, either pre-formed or newly synthesized, upon appropriate stimulation. CCL-2 chemokine and TNF cytokine act as potent chemoattractants for several immune cells and participate in the initiation of inflammatory responses by recruiting them to injured tissues. TGF-β regulates CCL-2 and TNF secretion in different cell types and under distinct cellular contexts. Here, we report that the treatment with TGF-β alone induces the secretion of both pre-formed and newly synthesized CCL-2 in the rat RBL-2H3 mast cells but not in mouse bone marrow-derived mast cells (BMMCs). TGF-β-induced CCL-2 secretion depends on rapid rearrangements of the actin cytoskeleton and, remarkably, on the early secretion of soluble TNF that triggers an autocrine TNF signaling. In conclusion, we found cooperation between TGF-β and TNF signaling pathways to promote the secretion of CCL-2 chemokine by MCs in a cell-context specific manner.

## Linked entities

- **Proteins:** TGFB1 (transforming growth factor beta 1), CCL2 (C-C motif chemokine ligand 2), TNF (tumor necrosis factor)
- **Species:** Rattus norvegicus (taxon 10116), Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** Tnf (tumor necrosis factor) [NCBI Gene 24835] {aka RATTNF, TNF-alpha, Tnfa}, Tgfb1 (transforming growth factor, beta 1) [NCBI Gene 59086] {aka Tgfb}, Ccl2 (C-C motif chemokine ligand 2) [NCBI Gene 24770] {aka MCP-1, MCP1, Scya2, Sigje}, Tumor Necrosis Factor [NCBI Gene 103694380]
- **Diseases:** inflammation (MESH:D007249), cancer (MESH:D009369)
- **Species:** Mus musculus (house mouse, species) [taxon 10090], Rattus norvegicus (brown rat, species) [taxon 10116]
- **Cell lines:** RBL-2H3 — Rattus norvegicus (Rat), Rat leukemia, Cancer cell line (CVCL_0591), Basophilic — Rattus norvegicus (Rat), Rat leukemia, Cancer cell line (CVCL_0496), Leukemia-2H3 — Homo sapiens (Human), Childhood B acute lymphoblastic leukemia, Cancer cell line (CVCL_6G43)

## Figures

7 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12071771/full.md

---
Source: https://tomesphere.com/paper/PMC12071771